Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1515 of 6351
-
Can a smartphone app keep heart attack patients out of the ER?
Disease control Not yet recruitingHeart attacks are one of the top causes of death in Canada, with over 2,100 cases treated each year in Manitoba. Even though hospital care has improved, the period after going home is still risky. Many patients feel anxious and unsure about their recovery, and without enough supp…
Sponsor: St. Boniface Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:34 UTC
-
New eczema drug CM512 tested for Long-Term safety in 246 patients
Disease control Recruiting nowThis is an Open-label ,Multicenter Study to evaluate Long-Term Safety and Efficacy of CM512 in patients with Atopic Dermatitis who have completed treatment in parent CM512 Study.
Phase 2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for advanced prostate cancer: combination therapy enters human trials
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety of the combination therapy of Lutetium (177Lu) DGUL and pembrolizumab. It will also assess the antitumor efficacy and pharmacokinetics of the combination therapy compared to Lutetium (177Lu) DGUL monotherapy. Participants…
Phase 1 • Sponsor: Cellbion Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New pill aims to tame dangerous phosphate in kidney patients
Disease control Recruiting nowA clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.
Phase 3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug aims to tame rare, Exercise-Triggered heart condition
Disease control Recruiting nowThis is a Phase 2, multicenter, double-blind, sponsor blinded, placebo-controlled, repeat-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CRD-4730 to participants with Catecholaminergic Polymorphic Ventricu…
Phase 2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New sedative may cut delirium risk in elderly heart surgery patients
Symptom relief Not yet recruiting"Postoperative delirium is a common and serious complication following cardiac surgery, particularly among older adults who require intensive care. Its incidence is reported to range between 20% and 70% after cardiopulmonary bypass (CPB), and has been associated with prolonged ho…
Phase 4 • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New immunotherapy cocktail takes on stubborn colorectal cancer
Disease control Recruiting nowPhase 1b/2 open-label study evaluates the safety, tolerability, and efficacy of combination immunotherapy with nadunolimab (anti-IL-1RAP) and toripalimab (anti-PD-1) in patients with chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer. Phase 1b will a…
Phase 1/2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can vitamin B12 restore your voice after thyroid surgery? new trial aims to find out
Symptom relief Not yet recruitingRecurrent laryngeal nerve injury is one of the most common and serious complications affecting quality of life after thyroid surgery. Intraoperative traction, clamping, thermal injury, or direct transection can lead to its dysfunction. Unilateral injury causes vocal cord paralysi…
Phase 3 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can a Two-Drug antiviral combo boost survival in liver cancer patients?
Disease control Not yet recruitingStudy Objective: To compare the efficacy and prognosis of systemic cancer therapy between TAF monotherapy and ETV plus TAF combination therapy in patients with unresectable, advanced hepatitis-B-related hepatocellular carcinoma (HBV-HCC). Study Design: Prospective, interventiona…
Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Smart knees that catch you when you trip: new trial tests stumble recovery tech
Disease control OngoingThe study aims to conduct a formative evaluation, along with verification, validation, and comparative analysis of the stumble recovery function in prosthetic devices by collecting relevant clinical data. The study will involve participants who are current users of lower-limb pro…
Sponsor: Össur Iceland ehf • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a common amino acid fix Stroke-Related balance problems?
Symptom relief Recruiting nowAlong with the current clinical trial, the efficacy and safety of 4 gram of acetyl-leucine daily for three months in patients with post-stroke ataxia following posterior-circulation ischaemic stroke assessed through BBS, SARA, and mRS, and possible adverse effects.
Phase 3 • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Spit test could spot gum disease before It's too late
Diagnosis Not yet recruitingThis observational study aims to develop and validate a novel, AI-assisted electrochemical sensor platform for saliva-based diagnostics in periodontitis. Periodontitis is a chronic inflammatory disease affecting the gums and supporting tissues of the teeth. Despite its high globa…
Sponsor: Ostergotland County Council, Sweden • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Heated chemo bath during stomach cancer surgery shows promise
Disease control Recruiting nowThe study investigates the outcomes of hyperthermic intraperitoneal chemoperfusion (HIPEC) in combination with curative-intent gastrectomy in resectable locally-advanced and limited-metastatic (low peritoneal cancer index) gastric cancer.
Sponsor: Ukrainian Society of Clinical Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Sweat it out: High-Intensity workouts may boost language recovery after stroke
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate the effects of a high-intensity exercise program on recovery in individuals with post-stroke aphasia. The high-intensity exercise program has been specifically designed for individuals with post-stroke aphasia and includes an interva…
Sponsor: University of California, Berkeley • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New combo aims to free ITP patients from lifelong medication
Disease control Not yet recruitingThis study is an open label, randomized controlled, multicenter clinical trial aimed at comparing the efficacy and safety of the combination of atorvastatin and all trans retinoic acid with atorvastatin alone in the treatment of first-line ineffective or recurrent immune thromboc…
Phase 2/3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New cocktail of drugs aims to shrink Hard-to-Treat abdominal tumors
Disease control Not yet recruitingAssuming that the objective response rate (ORR) of neoadjuvant chemotherapy in patients with colorectal cancer peritoneal metastasis is approximately 0.40 , a total sample size of 30 patients is required. Step 1: Ten patients will be initially enrolled. If the number of respond…
Phase 2 • Sponsor: Guoxiang Cai • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New bead therapy may improve liver cancer treatment after shunt procedure
Disease control Recruiting nowThis is a Phase 3, open-label, multicenter, randomized controlled clinical trial designed to evaluate the efficacy and safety of Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) compared with Conventional Transarterial Chemoembolization (cTACE) in patients with hepato…
Phase 3 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Real-World data on glofitamab shows promise for Tough-to-Treat lymphoma
Knowledge-focused Recruiting nowTo date, more than 300 patients have been treated with Glofitamab in the Expanded Access Programme (EAP) in France. In this study, it is proposed to perform a retrospective analysis of some of these patients. The aim is to describe the efficacy and safety of Glofitamab in the lar…
Sponsor: The Lymphoma Academic Research Organisation • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Could inhaled TB drugs curb the spread of Drug-Resistant tuberculosis?
Disease control Recruiting nowRationale: To halt the global tuberculosis (TB) crisis, and particular the ongoing threat of drug-resistant TB (DR-TB), it is essential to reduce transmission. This could be done by shortening the period that patients with pulmonary TB secrete viable bacilli, and are therefore c…
Phase 1 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can smarter antibiotic use curb Drug-Resistant infections?
Knowledge-focused OngoingThe main goal of this retrospective observational study is to understand how stepping down antibiotic treatment (called antibiotic de-escalation) affects patients who receive it compared to those who don't after received a short-course (≤7 days) of parenteral antibiotics. The inv…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC